Back to Search
Start Over
Role of NRF2 and Sirtuin activators in COVID-19.
- Source :
-
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Dec; Vol. 233, pp. 108879. Date of Electronic Publication: 2021 Nov 16. - Publication Year :
- 2021
-
Abstract
- COVID-19 is a pandemic requiring immediate solution for treatment because of its complex pathophysiology. Exploration of novel targets and thus treatment will be life savers which is the need of the hour. 2 host factors- TMPRSS2 and ACE2 are responsible for the way the virus will enter and replicate in the host. Also NRF2 is an important protein responsible for its anti-inflammatory role by multiple mechanisms of action like inhibition of NF-kB, suppression of pro-inflammatory genes, etc. NRF2 is deacetylated by Sirtuins and therefore both have a direct association. Absence of SIRT indicates inhibition of NRF2 expression and thus no anti-oxidative and anti-inflammatory protection for the cell. Therefore, we propose that NRF2 activators and/or SIRT activators can be evaluated to check their efficacy in ameliorating the symptoms of COVID-19.<br /> (Copyright © 2021. Published by Elsevier Inc.)
- Subjects :
- Angiotensin-Converting Enzyme 2 immunology
Angiotensin-Converting Enzyme 2 metabolism
Animals
COVID-19 metabolism
COVID-19 virology
Host-Pathogen Interactions immunology
Humans
NF-E2-Related Factor 2 metabolism
SARS-CoV-2 metabolism
SARS-CoV-2 physiology
Serine Endopeptidases immunology
Serine Endopeptidases metabolism
Sirtuins metabolism
Virus Attachment
COVID-19 immunology
NF-E2-Related Factor 2 immunology
SARS-CoV-2 immunology
Sirtuins immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1521-7035
- Volume :
- 233
- Database :
- MEDLINE
- Journal :
- Clinical immunology (Orlando, Fla.)
- Publication Type :
- Academic Journal
- Accession number :
- 34798239
- Full Text :
- https://doi.org/10.1016/j.clim.2021.108879